HAVE ANY QUESTIONS? CLICK HERE
Covid-19 pandemic : Biomatlante continues its activity
- Biomatlante News
Covid-19 pandemic : Biomatlante continues its activity
Congratulations from Biomatlante team!
BIOMATLANTE joins the AMS Group
- Biomatlante News
Biomatlante is very pleased to announce the acquisition of 100% of its shares by Advanced Medical Solutions Group plc (London Alternative Investment Market: AMS).
Biomatlante: a new step towards the MDR
- Biomatlante News
Just after BSI last January, TÜV Süd Product Service GmbH is now the second Notified Body designated to issue CE Marking certifications under the European Medical Devices Regulation (MDR).
Biomatlante receives MDSAP Accreditation
- Biomatlante News
Biomatlante, a world leader in synthetic bone regeneration technologies, is pleased to announce the obtention of the MDSAP* accreditation on the new ISO 13485:2016 Certificate.
BIOMATLANTE announces the appointment of its new CEO
- Biomatlante News
Julien Dert named as new CEO of Biomatlante, Chantal Gobin continues as Chairman of the Board
Biomatlante, a world leader in synthetic bone regeneration technologies, is pleased to announce the appointment of its new CEO, Julien Dert, being effective on February 1st, 2019.
Biomatlante, has been at the forefront of development of new synthetic bone graft.
5 Rue Edouard Belin, 44360 Vigneux-de-Bretagne, France
+33 2 28 02 00 09
Contact@biomatlante.com
5 Rue Edouard Belin, 44360 Vigneux-de-Bretagne, France
+33 2 28 02 00 09
Contact@biomatlante.com